(Q41676961)

English

Dose-response relationships for the antipsychotic effects and Parkinsonian side-effects of typical neuroleptic drugs: practical and theoretical implications

scientific article published on October 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

1 reference

Europe PubMed Central

Dose-response relationships for the antipsychotic effects and Parkinsonian side-effects of typical neuroleptic drugs: practical and theoretical implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Miller R

1

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

1059-1094

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions between procyclidine and neuroleptic drugs. Some pharmacological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with the use of chlorpromazine and reserpine in psychiatry, with special reference to the significance and management of extrapyramidal dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of the need for anticholinergic medication in patients treated with long-term antipsychotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Depot Phenothiazine Treatment in Acute Psychosis: A Sequential Comparative Clinical Study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic-induced supersensitivity psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug Treatment in Newly Admitted Schizophrenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma Level Monitoring of Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental neurological syndromes and the new drug therapies in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Catatonic behavior induced by haloperidol, increased by retesting and elicited without drug in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol for acute schizophrenic patients. An evaluation of three oral regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluphenazine pharmacokinetics and therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical confirmation of Heistad's predictions.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical treatments for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine treatment. A controlled prospective handwriting-test study in 22 acutely ill schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug and Family Therapy in the Aftercare of Acute Schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of fluphenazine, trifluoperazine and a placebo in the context of an active treatment unit

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Behavioral effects of clozapine and dopamine receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic-induced catalepsy: a D2 blockade phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating the Long-Term Need for Antiparkinson Drugs by Chronic Schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental comparison of the effectivity of individually adapted and standardized dosages of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Very high dose loxapine in refractory schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic plasma level may predict response in patients who meet a criterion for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs and benefits of two doses of fluphenazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting outcome of antipsychotic drug treatment from early response

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute effects of neuroleptics on unmedicated schizophrenic patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of a low dose neuroleptic treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Major psychosis and dopamine: controversial features and some suggestions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperactivity of associations in psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Behavioral considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The prediction of acute response, remission and general outcome of neuroleptic treatment in acute schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic effect of neuroleptics in symptom-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic effect of neuroleptics in symptom-free schizophrenics: a comparative dose-response study of haloperidol and propericiazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High Dose Trifluoperazine Therapy in Chronic Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute schizophrenia with ultra-high-dose fluphenazine: A failure at shortening time on a crisis-intervention unit

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosage of haloperidol for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic Concentrations and Clinical Response

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled comparison of the treatment of schizophrenic patients when treated according to the neurologic threshold or by clinical judgment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antiparkinsonian medication on plasma levels of chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug history and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid tranquilization: a reevaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction of drug effects with testing procedures in the measurement of catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Total and free plasma neuroleptic levels in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled dose comparison of haloperidol in newly admitted schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol plasma levels and clinical response: a therapeutic window relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol blood levels and clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Trifluoperazine: A comparison between regular and high doses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Do Anticholinergics Antagonize Antipsychotic Drug Action?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900099-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0278-5846(97)00099-7

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41676961&oldid=1925856102"